| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V52750 | 4-Phenylbutyric acid-d2 (4-PBA-d2; Benzenebutyric acid-d2) | 461391-24-2 | 4-Phenylbutyric acid-d2 is the deuterated form of 4-Phenylbutyric acid. |
|
V54445 | AG-7404 | 343565-99-1 | AG-7404 is a picornavirus 3C protease inhibitor (antagonist) with anti-poliovirus activity (EC50=0.080-0.674 μM). |
|
V130117 | BFB78 | BFB78 is an nsP2 protease inhibitor that can cross the blood-brain barrier. | |
|
V78142 | HCVcc-IN-2 | 2977251-02-6 | HCV (hepatitis C virus)cc-IN-2 is a benzothiazole-2-thiophene S-glycoside analogue with antitumor and antiviral effect. |
|
V54446 | Herpes virus inhibitor 1 | 103424-73-3 | Herpes virus inhibitor 1 is a herpes virus inhibitor that disrupts the quaternary structure of herpes virus ribonucleotide reductase. |
|
V115208 | JMX0254 | 2375960-04-4 | JMX0254 is an orally effective and potent dengue virus NS4B inhibitor. |
|
V111157 | MTase-IN-2 | MTase-IN-2 (compound 32) is a potent NS5 methyltransferase inhibitor with an IC50 value of 2.14 μM against the dengue virus (DENV3) MTase domain and 2.01 μM against the Zika virus (ZIKV) NS5 MTase domain. | |
|
V88339 | NS2B/NS3-IN-8 | 1021221-94-2 | NS2B/NS3-IN-8 (compound MH1) is a Zika virus NS2B-NS3 protease inhibitor. |
|
V119073 | SARS-CoV-2 main protease | The SARS-CoV-2 main protease (Mpro) is the main protease of SARS-CoV-2 and plays a central role in viral replication and transcription, thus making it an attractive drug target in COVID-19 research. | |
|
V36591 | SID-852843 | 909859-19-4 | SID-852843 is a WNV NS2B-NS3 protease inhibitor. |